Explore the benefits and considerations of adjuvant immunotherapy in the treatment of resectable non-small cell lung cancer (NSCLC). Review the latest clinical trials, including IMpower 010 and Checkmate 816, and learn about the potential role of neoadjuvant therapy.

11 views • 28 slides

Cancer care in India is undergoing a paradigm shift with the introduction of a new immunotherapy treatment: Dostarlimab. This potent formulation (7.5 mg\/5 ml) promises to change the treatment paradigm for oncologists as well as patients fighting cancer. Dostarlimab 7.5 mg\/5 ml is a revolutionary i

5 views • 7 slides

Guidelines and characteristics of invasive lobular carcinoma, focusing on oncological challenges, response to chemotherapy, and prognosis after neo-adjuvant treatment in patients. Highlights the importance of considering histology type for tailored treatment decisions. Discusses the effectiveness of

0 views • 20 slides

The Global Cancer Immunotherapy Market was valued at $39.86 billion in 2017 and is anticipated to reach $170.70 billion by 2028 during the forecast period of 2017-2028 and still the market is showing an increase in the ROI in the later years as well.

0 views • 3 slides

Explore the evolution of perioperative treatment for lung cancer from historical perspectives to current advancements. Learn about the efficacy of different chemotherapy agents, immunotherapies, and adjuvant treatments, along with the impact on patient outcomes and resectability criteria. Discover t

0 views • 19 slides

POSNOC (Positive Sentinel Node) and ATNEC trials are investigating the effectiveness of axillary treatment in women with early-stage breast cancer having metastases in one or two sentinel nodes. Led by Chief Investigator Amit Goyal in the UK, this randomized controlled trial compares adjuvant therap

1 views • 21 slides

This trial aims to compare the efficacy and safety of molecularly-guided therapy or cancer immunotherapy based on genomic profiling with platinum-based chemotherapy in patients with cancer of unknown primary site. The study design includes multiple treatment regimens guided by genomic profiles, with

1 views • 9 slides

The updates to the 2014 Primary Healthcare Implementation Slides focus on pain control for children, including the addition of ibuprofen and exclusion of tramadol for moderate pain. The management of acute severe pain involves retaining morphine injection while omitting metocloperamide, paracetamol,

0 views • 10 slides

Adjuvants are additives that enhance herbicide effectiveness, crucial for optimal weed control. Types include surfactants, stabilizing agents, coupling agents, humectants, deposit builders, and more. Surfactants aid in wetting and spreading herbicides, stabilizing agents keep suspensions intact, cou

0 views • 10 slides

Extended adjuvant endocrine therapy may benefit breast cancer patients with poor or intermediate prognosis, but may have little value for those with good prognosis. Risks include osteoporosis and venous thromboembolism. Different treatment options are available for postmenopausal and premenopausal w

0 views • 9 slides